Analyst Upside Underscores Impressive Growth for Amgen Inc. (NASDAQ:AMGN)

Shaers of Amgen Inc. (NASDAQ:AMGN) have been recommended as a long term growth pick.  With the firm’s stock price currently trading around $170.13, the firm has proven a solid track record of growth over the recent years.  Investors might consider the stock as a long term growth candidate as the firm has yielded 20.50% earnings per share growth over the past 5 years and 8.10% revenue growth over that same time frame. 

Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time.  Long-term growth should be considered to be a relative term, due to different styles and goals of investors, but the endgame is the same. 

Recent Performance

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, Amgen Inc. (NASDAQ:AMGN)’s stock was 16.36%.  Over the last week of the month, it was -1.93%, -0.74% over the last quarter, and  8.32% for the past six months. 

Over the past 50 days, Amgen Inc.’s stock is -10.97% off of the high and 0.26% removed from the low.  Their 52-Week High and Low are as follows: -10.97% (High), 22.55%, (Low). 

Analyst Recommendation

Despite the past success, investors want to know where the stock is headed from here.  Analysts covering the shares have a consensus short-term price target of $189.86 on the equity.   Analysts have a consensus recommendation of 2.50 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  

Leave a Comment